Italy's 2026 Budget Law has allocated EUR 238 million per year to extend and strengthen national cancer screening programmes.[1] The changes are substantial: biennial mammography now covers women aged 45-49 and 70-74, colorectal screening extends to the 70-74 age group, and the lung cancer programme is consolidated nationally. According to AIOM, Italy expects 390,700 new cancer diagnoses in 2025.[3] Early diagnosis is the intervention with the highest cost-benefit ratio in oncology. And the family physician is at the centre of this chain.
The GP's role in cancer screening — 4 concrete responsibilities
Identify eligible patients
Every year, the GP must check which patients meet the age criteria for the new screening programmes. With the 2026 extensions, the eligible population grows significantly.
Prescribe and send invitations
In many regions the GP is the first point of contact for screening invitations. The invitation letter, adherence and follow-up often go through the family physician's practice.
Manage results and follow-ups
A positive screening result generates a documentation cascade: letter to patient, specialist referral, clinical note, health record update. Every positive screening = 20-30 minutes of documentation.
Document in the FSE
From 31 March 2026, oncological follow-up documents must be uploaded to the FSE within 5 days. Structuring screening notes in HL7 CDA2 requires adequate tools.
The 4 responsibilities of the family physician in managing new 2026 cancer screening programmes
The calculation of additional documentary burden
A GP with 1,500 patients has on average 600-700 women aged 45-74. With the breast screening age extension, approximately 200 of these now enter an active programme for the first time. If the expected adherence rate is 60%, this means 120 new screening procedures per year to manage — invitation, follow-up, FSE documentation. At 25 minutes per positive case, that is 50 additional hours of work per year for breast screening alone.
The data leaves no doubt about effectiveness. Organised breast cancer screening reduces mortality by 25-40% in women who participate. For colorectal cancer, identifying precancerous lesions through a positive FIT test followed by colonoscopy reduces mortality by 18-33%.[3]
The problem is not willingness. The problem is time. A GP with 1,500 patients who must systematically manage screening programmes for breast, colorectal, cervical, lung cancer and the new neonatal programmes faces a documentary burden that, without adequate tools, is simply unsustainable.
Cancer prevention is one of the most effective investments in public health. But for it to work, the family physician needs the time to actually do it — not just tick a box. Reducing documentary burden is the precondition for quality prevention.
See also our articles on FSE 2.0 and physician obligations, on automatic SOAP notes and on waiting lists in Italy.
What are the new age groups for breast cancer screening in 2026?
The 2026 Budget Law extends biennial mammography screening to the 45-49 and 70-74 age groups, in addition to the 50-69 age group already covered. In practice, almost all women between 45 and 74 now fall within an active screening programme. For the GP, this means systematically reviewing patients in these groups and ensuring they have received and followed up on their invitation, documenting adherence status in the health record.
How does the GP's documentary burden change with the screening extension?
Significantly. For every screening-positive patient, the GP must produce: a clinical note with the result, a specialist referral letter, a health record update, and often a patient letter explaining the next steps. With FSE 2.0 mandatory from 31 March 2026, these documents must be structured and uploaded within 5 days. On a list of 1,500 patients, with the new age groups, an increase of 200-400 screening procedures per year is estimated — and a proportional number of documentary follow-ups.
How can AI help in managing cancer screening?
On three concrete fronts. First: automatic identification of eligible patients — an AI tool integrated with the management software can automatically flag patients entering the new age groups at the time of visit. Second: follow-up documentation generation — structured clinical notes, specialist referral letters and FSE updates generated automatically from visit transcription reduce documentation time per screening from 20-30 minutes to under 3 minutes. Third: adherence monitoring — an AI system can track patients who have not yet completed screening and suggest a reminder at the next visit.
Generate follow-up letters, screening notes, specialist referrals — automatically, in Italian, ready for the FSE. No data sent to non-European servers. GDPR Art. 9 compliant.
Try free for 14 days →